All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Immunosuppressants

Enspryng

(satralizumab)

Uses, side effects, dosage information & price range

Roche Registration GmbH

About this medicine

Satralizumab (Enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (IST) for the treatment of neuromyelitis optica spectrum disorders (NMOSD) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 IgG (AQP4-IgG) seropositive.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

Pomalidomide ZentivaComposition: pomalidomideZentiva, k.s.
Price on RequestView Details →
UpliznaComposition: inebilizumabAmgen Europe B.V.
Price on RequestView Details →
VeblocemaComposition: infliximabCelltrion Healthcare Hungary Kft.
Price on RequestView Details →
AravaComposition: leflunomideSanofi-aventis Deutschland GmbH
Price on RequestView Details →
CimziaComposition: certolizumab pegolUCB Pharma
Price on RequestView Details →

Key Information

Salt / Composition

satralizumab

Category

Immunosuppressants

Manufacturer

Roche Registration GmbH

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.